Abstract Background The Gastrointestinal Surgery Center (GISC)—Mansoura University,
faced a series of extensive drug resistant (XDR) A. baumannii cases, that were …

Several antimicrobial combination therapies are used to treat multiple drug resistant (MDR)
and extensively drug resistant (XDR) Acinetobacter baumannii infections. A novel antibiotic …

Although the prevalence of species of the genus Acinetobacter other than Acinetobacter
baumannii has seemingly increased as a cause of nosocomial infections in different …

Colistin and tigecycline are the only therapeutic options for extensively drug resistant
Acinetobacter baumannii (XDR-AB), but there is little comparative study. This retrospective …

Background Infections sustained by multidrug-resistant (MDR) and pan-resistant
Acinetobacter baumannii have become a challenging problem in Intensive Care Units …

Introduction: Although the clinical importance of Acinetobacter pittii and Acinetobacter
nosocomialis has increased in the nosocomial setting in the last decade, infections caused …

The existence of infections caused by multidrug resistant (MDR) Acinetobacter baumannii is
a growing problem because of the difficulty to treat them. We examined the published …

The study investigated the effect of antibiotic combinations against 20 clinical isolates of A.
baumannii (seven colistin-resistant and 13 colistin-susceptible) with different resistance …

Acinetobacter baumannii has emerged worldwide as an important nosocomial and
opportunistic pathogen, particularly in intensive care units (7). Treatment is difficult due to …

Introduction: In just two decades Acinetobacter baumannii has attained considerable
importance, evolving from an insignificant organism to a leading pathogen especially in …